Revenue
Collaboration Revenue
+0.77%
+7.96%
COVID-19 Revenue
+2.32%
+25.8%
Other Medicines Revenue
-0.91%
-8.73%
Rare Disease Revenue
+0.41%
+4.14%
BioPharmaceuticals: CVRM Revenue
-1.96%
-17.95%
BioPharmaceuticals V&I Revenue
-0.38%
-3.69%
Revenue by Geography
The Americas Revenue
-0.19%
-1.84%
Rest of Europe Revenue
+1.25%
+13.18%
Asia, Africa & Australasia Revenue
-1.54%
-14.4%
EBIT by Geography
The Americas Operating Profit
+2.67%
+30.18%
UK Operating Profit
+0.16%
+1.66%
Rest of Europe Operating Profit
+2.83%
+32.23%
Asia, Africa & Australasia Operating Profit
+1.68%
+18.17%
Capital Expenditures by Geography
Rest of Europe Assets Acquired
+1.73%
+18.71%
Asia, Africa & Australasia Assets Acquired
+1.22%
+12.88%
UK Assets Acquired
-0.89%
-8.58%
The Americas Assets Acquired
-0.27%
-2.63%
